Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Hemorrhagic complications of anticoagulant treatment.

Levine MN, Raskob G, Landefeld S, Kearon C.

Chest. 2001 Jan;119(1 Suppl):108S-121S. Review.

PMID:
11157645
2.

Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S.

Chest. 2004 Sep;126(3 Suppl):287S-310S. Review.

PMID:
15383476
3.

Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.

Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM.

Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28. Review.

PMID:
22744711
4.

Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.

[No authors listed]

Prescrire Int. 2013 Apr;22(137):99-101, 103-4. Review.

PMID:
23662321
5.

Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs.

Bounameaux H, de Moerloose P, Sarasin FP.

Blood Coagul Fibrinolysis. 1996 Jul;7(5):507-14. Review.

PMID:
8874860
6.

Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.

DeLoughery TG.

Crit Care Clin. 2005 Jul;21(3):497-512. Review.

PMID:
15992670
7.
8.

Long-term treatment of venous thromboembolism with low-molecular-weight heparin.

Monreal M.

Curr Opin Pulm Med. 2000 Jul;6(4):326-9. Review.

PMID:
10912641
9.

Hemorrhagic complications of oral anticoagulant therapy.

Beyth RJ.

Clin Geriatr Med. 2001 Feb;17(1):49-56. Review.

PMID:
11270133
10.

[Anticoagulation of valvular prostheses].

Hanania G, Maroni JP, el Hajj Y.

Ann Cardiol Angeiol (Paris). 2003 Nov;52(5):290-6. Review. French.

PMID:
14714342
11.
12.

Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication.

Cosmi B, Conti E, Coccheri S.

Cochrane Database Syst Rev. 2001;(3):CD001999. Review. Update in: Cochrane Database Syst Rev. 2014;5:CD001999.

PMID:
11687006
13.
14.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Becattini C, Vedovati MC, Agnelli G.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20. Review.

PMID:
22264937
16.

[Bleeding complications in oral anticoagulant treatment].

Gulløv AL, Koefoed BG, Petersen P.

Nord Med. 1995;110(4):114-8. Review. Danish.

PMID:
7724354
17.

Risk of haemorrhage associated with long term anticoagulant therapy.

Levine MN, Raskob G, Hirsh J.

Drugs. 1985 Nov;30(5):444-60. Review.

PMID:
3905338
18.
20.

Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.

Algra A, De Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001342. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD001342.

PMID:
16855967

Supplemental Content

Support Center